August 21, 2012 08:00 ET

Equity Research on Amedisys Inc. - Reimbursement Rates and Cost Pressures Hitting Home Health Care

NEW YORK, NY--(Marketwire - Aug 21, 2012) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Home Health Care industry and are offering free analytical research on Amedisys Inc. (NASDAQ: AMED). Register with us now to have free access to this research report. Simply click on the link below.

A reduction in Medicare reimbursement rates has taken its toll on a number of companies in the home health care industry, and with no changes forthcoming, industry players could continue to face challenges through 2012 and into 2013. Shrinking margins have also been a concern for several companies, including Amedisys Inc. That being said, an aging population in the U.S. and an improving economy could work in favor of the industry moving forward. Get your free report on Amedisys Inc. at There is no commitment to join. is the Ultimate Trading Environment for investors. If you are considering owning Amedisys Inc. then you should sign up for a free membership and our complimentary report today. Over the last 5 years our returns outpaced any of the major indexes. Sign up today by clicking on the link below to find out what you are missing.

Acquisitions and quarterly reports have also been making headlines as of late, and investors are getting a better look at how companies are planning for the future. For example, Linde Group recently increased its holdings in the respiratory care field with the acquisition of Lincare Holdings Inc.

Conversely, Amedisys Inc. had a difficult 2nd quarter, as net income from continuing operations fell by 65.1% when compared to the same period last year. The company is hoping to turn things around in the upcoming quarter, and is focusing on its home health and hospice patients. Amedisys Inc. report is accessible for free by registering today at

The Home Health Care stock research report is available for free by signing up now on the link below.


Shine's Rooms is the brain child of David Shine, a 13 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information